-
1
-
-
62349118969
-
Evaluation and management of adult hypoglycemic disorders: An endocrine society clinical practice guideline
-
19088155
-
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009; 94:709-728 doi: 10.1210/jc.2008-1410 PMID: 19088155
-
(2009)
J Clin Endocrinol Metab.
, vol.94
, pp. 709-728
-
-
Cryer, P.E.1
Axelrod, L.2
Grossman, A.B.3
Heller, S.R.4
Montori, V.M.5
Seaquist, E.R.6
-
2
-
-
0001720558
-
The surgical therapy of hyperinsulinism
-
Whipple AO 1938 The surgical therapy of hyperinsulinism.J Int Chir 3:237-276
-
(1938)
J Int Chir
, vol.3
, pp. 237-276
-
-
Whipple, A.O.1
-
3
-
-
62349142467
-
Glucose homeostasis and hypoglycemia
-
Kronenberg H, Melmed S, Polonsky K, Larsen P, eds 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc
-
Cryer P 2008 Glucose homeostasis and hypoglycemia. In: Kronenberg H, Melmed S, Polonsky K, Larsen P, eds. Williams textbook of endocrinology, 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc.; 1503-1533
-
(2008)
Williams Textbook of Endocrinology
, pp. 1503-1533
-
-
Cryer, P.1
-
4
-
-
42149161294
-
Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: Hypoglycaemia unawareness and attacks
-
Christesen HB, Brusgaard K, Beck Nielsen H, Brock Jacobsen B. Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks. Clin Endocrinol 2008; 68:747-755
-
(2008)
Clin Endocrinol
, vol.68
, pp. 747-755
-
-
Christesen, H.B.1
Brusgaard, K.2
Beck Nielsen, H.3
Brock Jacobsen, B.4
-
6
-
-
33846536315
-
Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: A diagnostic and therapeutic challenge
-
17263973
-
Raffel A, Krausch MM, Anlauf M, Wieben D, Braunstein S, Klöppel G, et al. Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge. Surgery. 2007; 141:179-184 PMID: 17263973
-
(2007)
Surgery.
, vol.141
, pp. 179-184
-
-
Raffel, A.1
Krausch, M.M.2
Anlauf, M.3
Wieben, D.4
Braunstein, S.5
Klöppel, G.6
-
8
-
-
0025834711
-
Functioning insulinoma - Incidence, recurrence, and long-term survival of patients: A 60-year study
-
1677058
-
Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66:711-719 PMID: 1677058
-
(1991)
Mayo Clin Proc
, vol.66
, pp. 711-719
-
-
Service, F.J.1
McMahon, M.M.2
O'Brien, P.C.3
Ballard, D.J.4
-
9
-
-
65249139010
-
Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007
-
19141587
-
Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009; 94:1069-1073 doi: 10.1210/jc.2008-2031 PMID: 19141587
-
(2009)
J Clin Endocrinol Metab.
, vol.94
, pp. 1069-1073
-
-
Placzkowski, K.A.1
Vella, A.2
Thompson, G.B.3
Grant, C.S.4
Reading, C.C.5
Charboneau, J.W.6
-
10
-
-
84976498082
-
Endoscopic ultrasound in endocrinology: Imaging of the adrenals and the endocrine pancreas
-
27003412
-
Kann PH. Endoscopic Ultrasound in Endocrinology: Imaging of the Adrenals and the Endocrine Pancreas. Front Horm Res. 2016; 45:46-54 doi: 10.1159/000442277 PMID: 27003412
-
(2016)
Front Horm Res.
, vol.45
, pp. 46-54
-
-
Kann, P.H.1
-
11
-
-
84962606474
-
Preoperative localization of an insulinoma: Selective arterial calcium stimulation test performance
-
26577133
-
Morera J, Guillaume A, Courtheoux P, Palazzo L, Rod A, Joubert M, et al. Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance. J Endocrinol Invest. 2016; 39:455-463 doi: 10.1007/s40618-015-0406-4 PMID: 26577133
-
(2016)
J Endocrinol Invest.
, vol.39
, pp. 455-463
-
-
Morera, J.1
Guillaume, A.2
Courtheoux, P.3
Palazzo, L.4
Rod, A.5
Joubert, M.6
-
12
-
-
57349195981
-
Peptide-based probes for cancer imaging
-
18927341
-
Reubi JC, Maecke HR. Peptide-Based Probes for Cancer Imaging. J Nucl Med. 2008; 49:1735-1738 doi: 10.2967/jnumed.108.053041 PMID: 18927341
-
(2008)
J Nucl Med.
, vol.49
, pp. 1735-1738
-
-
Reubi, J.C.1
Maecke, H.R.2
-
13
-
-
84455199744
-
Repeated cycles of peptide receptor radiobuclide therapy (PRRT)-Results and side-effects of the radioisotope 90YDOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA-TATE therapy in patients with disseminated NET
-
21885142
-
Pach D, Sowa-Staszczak A, Kunikowska J, Królicki L, Trofimiuk M, Stefanska A, et al. Repeated cycles of peptide receptor radiobuclide therapy (PRRT)-Results and side-effects of the radioisotope 90YDOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA-TATE therapy in patients with disseminated NET. Radiother Oncol. 2011; 102:45-50. doi: 10.1016/j.radonc.2011.08.006 PMID: 21885142
-
(2011)
Radiother Oncol.
, vol.102
, pp. 45-50
-
-
Pach, D.1
Sowa-Staszczak, A.2
Kunikowska, J.3
Królicki, L.4
Trofimiuk, M.5
Stefanska, A.6
-
14
-
-
77956183469
-
PET radiopharmaceuticals in radiation treatment planning - Synthesis and biological characteristics
-
20724013
-
Haubner R. PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics. Radiother Oncol. 2010; 96:280-287. doi: 10.1016/j.radonc.2010.07.022 PMID: 20724013
-
(2010)
Radiother Oncol.
, vol.96
, pp. 280-287
-
-
Haubner, R.1
-
15
-
-
84905024052
-
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors
-
24458014
-
Toumpanakis C, Kim MK, Rinke A, Bergestuen DS, Thirlwell C, Khan MS, et al. Combination of Cross-Sectional and Molecular Imaging Studies in the Localization of Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2014; 99:63-74 doi: 10.1159/000358727 PMID: 24458014
-
(2014)
Neuroendocrinology.
, vol.99
, pp. 63-74
-
-
Toumpanakis, C.1
Kim, M.K.2
Rinke, A.3
Bergestuen, D.S.4
Thirlwell, C.5
Khan, M.S.6
-
16
-
-
0032782401
-
Biological activity of GLP-1-analogues with N-terminal modifications
-
10100921
-
Siegel EG, Gallwitz B, Scharf G, Mentlein R, Morys-Wortmann C, Fölsch UR, et al. Biological activity of GLP-1-analogues with N-terminal modifications. Regulatory Peptides. 1999; 79:93-102 PMID: 10100921
-
(1999)
Regulatory Peptides.
, vol.79
, pp. 93-102
-
-
Siegel, E.G.1
Gallwitz, B.2
Scharf, G.3
Mentlein, R.4
Morys-Wortmann, C.5
Fölsch, U.R.6
-
17
-
-
0037907532
-
Concomitant expression of several peptide receptors in neuroendocrine tumours: Molecular basis for in vivo multireceptor tumour targeting
-
12707737
-
Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging. 2003; 30:781-793 PMID: 12707737
-
(2003)
Eur J Nucl Med Mol Imaging.
, vol.30
, pp. 781-793
-
-
Reubi, J.C.1
Waser, B.2
-
18
-
-
0029117847
-
Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas
-
7646446
-
Widmann Ch, Dolci W, Thorens B. Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. Biochem J. 1995; 310:203-214 PMID: 7646446
-
(1995)
Biochem J.
, vol.310
, pp. 203-214
-
-
Widmann, C.H.1
Dolci, W.2
Thorens, B.3
-
19
-
-
49449085799
-
Glucagon-like peptide 1-receptor scans to localize occult insulinomas
-
18703486
-
Wild D, Mäcke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med. 2008; 359:766-768. doi: 10.1056/NEJMc0802045 PMID: 18703486
-
(2008)
N Engl J Med.
, vol.359
, pp. 766-768
-
-
Wild, D.1
Mäcke, H.2
Christ, E.3
Gloor, B.4
Reubi, J.C.5
-
20
-
-
70449111654
-
Glucagon-like peptide 1-receptor imaging to localization of insulinomas
-
19820010
-
Christ E, Wild D, Forrer F, Brändle M, Sahli R, Clerici T, et al. Glucagon-like peptide 1-receptor imaging to localization of insulinomas. J Clin Endocrinol Metab. 2009; 94:4398-4405. doi: 10.1210/jc.2009-1082 PMID: 19820010
-
(2009)
J Clin Endocrinol Metab.
, vol.94
, pp. 4398-4405
-
-
Christ, E.1
Wild, D.2
Forrer, F.3
Brändle, M.4
Sahli, R.5
Clerici, T.6
-
21
-
-
84884502687
-
Glucagon-like peptide-1 receptor imaging for the localization of insulinomas: A prospective multicentre imaging study
-
24622317
-
Christ E, Wild D, Ederer S, Béhé M, Nicolas G, Caplin ME, et al. Glucagon-like peptide-1 receptor imaging for the localization of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol. 2013; 1:115-122 doi: 10.1016/S2213-8587(13)70049-4 PMID: 24622317
-
(2013)
Lancet Diabetes Endocrinol.
, vol.1
, pp. 115-122
-
-
Christ, E.1
Wild, D.2
Ederer, S.3
Béhé, M.4
Nicolas, G.5
Caplin, M.E.6
-
22
-
-
79960296365
-
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
-
21680696
-
Wild D, Christ E, Caplin ME, Kurzawinski TR, Forrer F, Brändle M, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-1078 doi: 10.2967/jnumed.110.085142 PMID: 21680696
-
(2011)
J Nucl Med
, vol.52
, pp. 1073-1078
-
-
Wild, D.1
Christ, E.2
Caplin, M.E.3
Kurzawinski, T.R.4
Forrer, F.5
Brändle, M.6
-
23
-
-
84899991622
-
Detection of metastatic insulinoma by positron emission tomography with [(68)Ga]exendin-4 - A case report
-
24512490
-
Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, et al. Detection of metastatic insulinoma by positron emission tomography with [(68)Ga]exendin-4 - a case report. J Clin Endocrinol Metab. 2014; 99:1519-1524 doi: 10.1210/jc.2013-3541 PMID: 24512490
-
(2014)
J Clin Endocrinol Metab.
, vol.99
, pp. 1519-1524
-
-
Eriksson, O.1
Velikyan, I.2
Selvaraju, R.K.3
Kandeel, F.4
Johansson, L.5
Antoni, G.6
-
24
-
-
77954986457
-
Exendin-4 based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT
-
20595511
-
Wild D, Wicki A, Mansi R, Béhé M, Keil B, Bernhardt P, et al. Exendin-4 based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med 2010; 51:1059-1067 doi: 10.2967/jnumed.110.074914 PMID: 20595511
-
(2010)
J Nucl Med
, vol.51
, pp. 1059-1067
-
-
Wild, D.1
Wicki, A.2
Mansi, R.3
Béhé, M.4
Keil, B.5
Bernhardt, P.6
-
25
-
-
84875745842
-
Glucagonlike peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma
-
Sowa-Staszczak A, Pach D, Mikolajczak R, Mäcke H, Jabrocka-Hybel A, Stefanska A, et al. Glucagonlike peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging. 2013; 40:524-531
-
(2013)
Eur J Nucl Med Mol Imaging.
, vol.40
, pp. 524-531
-
-
Sowa-Staszczak, A.1
Pach, D.2
Mikolajczak, R.3
Mäcke, H.4
Jabrocka-Hybel, A.5
Stefanska, A.6
-
27
-
-
34250732525
-
[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting
-
Wild D, Béhé M, Wicki A, Storch D, Waser B, Gotthardt M, et al
-
(2006)
J Nucl Med.
, vol.47
, pp. 2025-2033
-
-
Wild, D.1
Béhé, M.2
Wicki, A.3
Storch, D.4
Waser, B.5
Gotthardt, M.6
-
28
-
-
0036959991
-
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers
-
11889194
-
Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, et al. Effects of Glucagon-Like Peptide 1 on counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers. J Clin Endocrinol Metab. 2002; 87:1239-1246 PMID: 11889194
-
(2002)
J Clin Endocrinol Metab.
, vol.87
, pp. 1239-1246
-
-
Nauck, M.A.1
Heimesaat, M.M.2
Behle, K.3
Holst, J.J.4
Nauck, M.S.5
Ritzel, R.6
-
29
-
-
0027248866
-
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
-
8405741
-
Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 1993; 36:741-744 PMID: 8405741
-
(1993)
Diabetologia
, vol.36
, pp. 741-744
-
-
Nauck, M.A.1
Kleine, N.2
Orskov, C.3
Holst, J.J.4
Willms, B.5
Creutzfeldt, W.6
-
30
-
-
0030613750
-
Glucagon-like peptide 1 and its potential in the treatment of non-insulindependent diabetes mellitus
-
9370106
-
Nauck MA, Holst JJ, Willms B. Glucagon-like peptide 1 and its potential in the treatment of non-insulindependent diabetes mellitus. Horm Metab Res. 1997; 29:411-416 PMID: 9370106
-
(1997)
Horm Metab Res.
, vol.29
, pp. 411-416
-
-
Nauck, M.A.1
Holst, J.J.2
Willms, B.3
-
31
-
-
0030667056
-
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
-
9374685
-
Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997; 273: E981-E988 PMID: 9374685
-
(1997)
Am J Physiol.
, vol.273
, pp. E981-E988
-
-
Nauck, M.A.1
Niedereichholz, U.2
Ettler, R.3
Holst, J.J.4
Orskov, C.5
Ritzel, R.6
-
32
-
-
0030068620
-
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients
-
8550773
-
Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA, Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 1996; 81:327-332 PMID 8550773.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 327-332
-
-
Willms, B.1
Werner, J.2
Holst, J.J.3
Orskov, C.4
Creutzfeldt, W.5
Nauck, M.A.6
-
33
-
-
69949115448
-
No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects
-
Lerche S, Soendergaard L, Rungby J, Moeller N, Holst JJ, Schmitz OE, et al. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Clin Endocrin. 2009; 71:500-506
-
(2009)
Clin Endocrin.
, vol.71
, pp. 500-506
-
-
Lerche, S.1
Soendergaard, L.2
Rungby, J.3
Moeller, N.4
Holst, J.J.5
Schmitz, O.E.6
-
34
-
-
12844251849
-
Focal and diffuse forms of congenital hyperinsulinism: The keys for differential diagnosis
-
15640550
-
Sempoux C, Guiot Y, Jaubert F, Rahier J.Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocr Pathol. 2004; 15:241-246 PMID: 15640550
-
(2004)
Endocr Pathol.
, vol.15
, pp. 241-246
-
-
Sempoux, C.1
Guiot, Y.2
Jaubert, F.3
Rahier, J.4
-
35
-
-
34147154971
-
Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or betacell hyperplasia in adult patients
-
17227804, 1237-1244
-
Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, et al. Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or betacell hyperplasia in adult patients. J Clin Endocrinol Metab. 2007; 92:1237-1244 PMID: 17227804
-
(2007)
J Clin Endocrinol Metab.
, vol.92
-
-
Kauhanen, S.1
Seppänen, M.2
Minn, H.3
Gullichsen, R.4
Salonen, A.5
Alanen, K.6
|